[1]肖艳新,边志颖,赵新翠,等.代谢综合征患者血清色素上皮衍生因子水平变化的研究[J].国际内分泌代谢杂志,2016,36(06):366-369.[doi:10.3760/cma.j.issn.1673-4157.2016.06.02]
　Xiao Yanxin*,Bian Zhiying,Zhao Xincui,et al.Changes of serum pigment epithelium-derived factor in patients with metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(06):366-369.[doi:10.3760/cma.j.issn.1673-4157.2016.06.02]
点击复制

代谢综合征患者血清色素上皮衍生因子水平变化的研究()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
36
期数:
2016年06期
页码:
366-369
栏目:
论著
出版日期:
2016-11-20

文章信息/Info

Title:
Changes of serum pigment epithelium-derived factor in patients with metabolic syndrome
作者:
肖艳新; 边志颖; 赵新翠; 陈婕; 胡艳云; 孙倩; 白玉; 周荣华; 王君
071000 保定市第一中心医院内分泌科(肖艳新,边志颖,赵新翠,陈婕,胡艳云,孙倩,白玉,王君); 074300 保定市涞源县医院综合内科(周荣华)
Author(s):
Xiao Yanxin*; Bian Zhiying; Zhao Xincui; Chen Jie; Hu Yanyun; Sun Qian; Bai Yu; Zhou Ronghua;  Wang Jun.
*Department of Endocrinology,Baoding NO.1 Central Hospital,Baoding 071000,China
关键词:
代谢综合征;  色素上皮衍生因子;  纤维蛋白原;  胰岛素抵抗
Keywords:
Metabolic syndrome;  Pigment epithelium-derived factor;  Fibrinogen;  Insulin resistance
DOI:
10.3760/cma.j.issn.1673-4157.2016.06.02
摘要:
目的 探讨代谢综合征(MS)患者血清色素上皮衍生因子(PEDF)水平的变化及其在MS发生、发展中的意义。方法 将93例门诊及住院MS患者按指标异常个数分为3个代谢指标异常组(Ⅲ组,n=30)、4个代谢指标异常组(Ⅳ组,n=42)、5个代谢指标异常组(Ⅴ组,n=20)。35名门诊体检正常人群作为正常对照组(NC组)。采用酶联免疫吸附试验测定血清PEDF浓度,同时测量身高、体重、腰围、血压,测定血脂、空腹血糖、空腹胰岛素、血清纤维蛋白原含量,计算稳态模型评估-胰岛素抵抗指数(HOMA-IR)。采用多元逐步回归法分析PEDF的相关危险因素。结果 4组患者血清PEDF及纤维蛋白原水平逐渐升高(F=23.852、9.671,P均<0.01)。PEDF与体重指数、腰围、收缩压、舒张压、甘油三酯、纤维蛋白原、空腹血糖、空腹胰岛素、HOMA-IR呈正相关(r=0.253～0.440,P均<0.01),与高密度脂蛋白-胆固醇(HDL-C)呈负相关(r=-0.334,P<0.01)。纤维蛋白原、HDL-C、空腹血糖、HOMA-IR是PEDF的相关危险因素(t=-2.977～3.793,P均<0.05)。结论 随着MS代谢异常指标个数的增多,PEDF水平升高,且与糖、脂代谢紊乱和胰岛素抵抗相关。PEDF可能是MS发病的预测因子。
Abstract:
Objective To investigate the level of serum pigment epithelium-derived factor(PEDF)in patients with metabolic syndrome(MS)and its significance in the occurrence and development of MS. Methods A total of 93 outpatients and inpatients with MS were divided into three groups by the number of MS components: three abnormal components group(group Ⅲ,n=30), four abnormal components group(group Ⅳ,n=42)and five abnormal components group(group Ⅴ,n=21). A total of 35 normal subjects from outpatients received physical examination were included in control group. ELISA was used to detect the level of serum PEDF. Height, weight, waist circumference, blood pressure were measured and the level of blood lipid, fasting plasma glucose, fasting plasma insulin and fibrinogen were determined. Homeostatic model assessment of insulin resistance(HOMA-IR)was calculated. Multiple stepwise regression was used to analyze the related risk factors for PEDF. Results The level of serum PEDF and fibrinogen increased gradually in the four groups(F=23.852,9.671,all P<0.01). The level of PEDF was positively correlated with body mass index,waist circumstance,systolic blood pressure,diastolic blood pressure,triglycerides,fibrinogen, fasting plasma glucose, fasting plasma insulin and HOMA-IR(r=0.253-0.440, all P<0.01), but negatively correlated with HDL-C(r=-0.334,P<0.01). Fibrinogen,high density lipoprotein-cholesterol,fasting plasma glucose and HOMA-IR were risk factors of PEDF(t=-2.977-3.793,all P<0.05). Conclusions PEDF increases along with the increased number of abnormal components of MS. PEDF correlates with glycolipid metabolic disorders and insulin resistance and may have predictive value for the risk of MS.

参考文献/References:

[1] Spanidis Y, Mpesios A, Stagos D, et al. Assessment of the redox status in patients with metabolic syndrome and type 2 diabetes reveals great variations[J]. Exp ther Med, 2016, 11(3): 895- 903.DOI:10.3892/etm.2016.2968.
[2] Carnagarin R, Dharmarajan AM, Dass CR. PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes [J]. Mol Cell Endocrinol, 2016, 15(422):115-124. DOI:10.1016/j.mce.2015.12.010.
[3] Tryggestad JB, Wang JJ, Zhang SX, et al. Elevated plasma pigment epithelium-derived factor in children with type 2 diabetes mellitus is attributable to obesity [J]. Pediatr Diabetes,2015,16(8): 600-605. DOI:10.1111/pedi.12226.
[4] Dai Z, Zhou T, Li C, et al. Intracellular pigment epithelium-derived factor contributes to triglyceride degradation[J]. Int J Biochem Cell Biol,2013, 45(9):2076-2086.DOI:10.1016/j.biocel.2013.07.008.
[5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013版)[J].中华糖尿病杂志,2014,6(7):447-498. DOI:10.3760/cma.j.issn.1674-5809.2014.07.004.
[6] Abramson LP, Stell mach V, Doll JA,et al. Wilm’s tumor growth is suppressed by antiangiogenic agent pigment epithelium-derived factor in axenograft model[J]. Pediatr Surg,2003,38(3):336-342.DOI:10.1053 /jpsu.2003.50104.
[7] Elahy M, Baindur-Hudson S, Cruzat VF,et al. Mechanisms of PEDF - mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy[J]. J Endocrinol, 2014, 222(3):129-139. DOI:10.1530/JOE-14-0065.
[8] Zhu XF, Zou HD. PEDF in diabetic retinopathy: a protective effect of oxidative stress[J]. J Biomed Biotechnol,2012,2012:580687.DOI: 10.1155/2012/580687.
[9] Choi KM,Hwang SY, Hong HC, et al. C1q/TNF-related protein-3(CTRP-3)and pigment epithelium-derived factor concentrations in patients with type 2 diabetes and metabolic syndrome[J]. Diabetes,2012,61(11): 2932-2936.DOI:10.2337/db12-0217.
[10] Aabater M,Moreno-Navarrete JM,Ortega FJ,et al. Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss[J]. J Clin Endoctinol Metab,2010,95(10):4728-4728.DOI:10.1210/jc.2010-0630.
[11] Mejias M, Coch L, Berzigotti A, et al. Antiangiogenic and antifibro-genic activity of pigment epithelium-derived factor(PEDF)in bile duct-ligated portal hypertensive rats[J]. Gut, 2015, 64(4):657-666.DOI:10.1136/gutjnl-20140307138.
[12] Stejskal D,Karpisek M,Svesyak M,et al. Pigment epithelium derived factor as a new marker of metabolic syndrome in Caucasian population[J]. J Clin Lab Anal,2010,24(1):17-19.DOI:10.1002/jcla.20360.
[13] Chen C, Tso AW, Law LS, et al. Plasma level of pigment epithelium-derived factor is independently associated with the develop ment of metabolic syndrome in Chinese men:a 10-year prospective study[J]. Clin Endocrinol Metab,2010,95(11):5074-5081.DOI:10.1210/jc.2010-0727.
[14] Guo M, Sahni SK,Sahni A,et al. Fibrinogen regulates the expression of inflammatory chemokines through NF-kappaB activation of endothelial cells[J]. Thromb Haemost,2004,92(4):858-866.DOI:10.1160/TH04-04-0261.
[15] Matsui T, Nishino Y, Ojima A,et al. Pigment epithelium-derived factor improves metabolic derangements and ameliorates dysregulation of adipocytokines in type 2 diabetic rats[J]. Am J Pathol,2014,184(4):1094-103.DOI:10.1016/j.ajpath.2013.12.032.
[16] Gattu AK, Birkenfeld AL, lwakiri Y,et al. Pigment epithelium derived factor suppresses IL-1 β-mediated c-Jun N-terminal kinase(JNK)activation to improve hepatocyte insulin signaling[J]. Endocrinology, 2014, 155(4):1271-1285.DOI:10.1210/en.2013-1785.
[17] Crowe S, Wu LE, Economou C, et al. Pigment epithelium derived factor contributes to insulin resistance in obesity[J]. Cell Metab, 2009, 10(1):40-47.DOI:10.1016/j.cmet.2009.06.001.
[18] Bell C. Pigment epithelium derived factor:a not so sympathetic regulator of insulin resistance?[J]. Exerc Sport Sci Rev,2011,39(4):187-190.DOI:10.1097/JES.0b013e31822673f0.
[19] Famulla S, Lamers D, Hartwig S, et al. Pigment epithelium derived factor is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cell[J].Int J Obes,2011,35(6):762-72.DOI:10.1038/ijo.2010.212.
[20] Carnagarin R,Dharmarajan AM, Dass CR,et al. PEDF induced alteration of metabolism leading to insulin resistance[J]. Mol Endocrinol,2015,5(401):98-104. DOI:10.1016/j.mce.2014.11.006.

相似文献/References:

[1]李建薇,田浩明.肝X受体与代谢综合征[J].国际内分泌代谢杂志,2007,(04):252.
[2]王滢,李倩.脑利钠肽与糖脂代谢的关系[J].国际内分泌代谢杂志,2015,(02):103.[doi:10.3760/cma.j.issn.1673-4157.2015.02.008]
　Wang Ying,Li Qian..Association between brain natriuretic peptide and glycolipid metabolism[J].International Journal of Endocrinology and Metabolism,2015,(06):103.[doi:10.3760/cma.j.issn.1673-4157.2015.02.008]
[3]赵娅,万沁.类胰蛋白酶与代谢综合征[J].国际内分泌代谢杂志,2015,(03):190.[doi:10.3760/cma.j.issn.1673-4157.2015.03.013]
　Zhao Ya,Wan Qin..Tryptase and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(06):190.[doi:10.3760/cma.j.issn.1673-4157.2015.03.013]
[4]盘庆飞,黄贤,李圣海.两种代谢综合征诊断标准在高血压 人群中的比较[J].国际内分泌代谢杂志,2017,37(02):86.[doi:10.3760/cma.j.issn.1673-4157.2017.02.004]
　Pan Qingfei,Huang Xian,Li Shenghai..Comparison of the two diagnostic criteria of metabolic syndrome among hypertensive population[J].International Journal of Endocrinology and Metabolism,2017,37(06):86.[doi:10.3760/cma.j.issn.1673-4157.2017.02.004]
[5]扬,徐书杭,黄华英,等.常州地区青少年人群不同代谢综合征诊断标准的比较研究[J].国际内分泌代谢杂志,2020,40(01):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
　iao Yang,Xu Shuhang,Huang Huaying,et al.A comparative study of the different diagnostic criteria for metabolic syndrome among adolescents in Changzhou area[J].International Journal of Endocrinology and Metabolism,2020,40(06):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
[6]应昉曹璐陈凤 许帅陈风郭妍王岩王涤非undefined.社区老年居民握力体重指数与代谢综合征的相关性[J].国际内分泌代谢杂志,2020,40(01):5.[doi:10. 3760/cma. j. issn. 1673-4157. 2020. 01.002]
　Wang Yingfang,Cao Lu,Chen Feng,et al.Relationship between handgrip strength body mass index and metabolic syndrome in community elderly residents[J].International Journal of Endocrinology and Metabolism,2020,40(06):5.[doi:10. 3760/cma. j. issn. 1673-4157. 2020. 01.002]

更新日期/Last Update: 2016-12-20